EnFix®
Augmentation of Rotator Cuff Repair (Enthesis Failure Syndrome)
ApprovedActive
Key Facts
Indication
Augmentation of Rotator Cuff Repair (Enthesis Failure Syndrome)
Phase
Approved
Status
Active
Company
About Tetrous
Tetrous is a medical technology company pioneering a novel approach to bone-to-tendon healing with its EnFix® product, a biologic scaffold designed to treat Enthesis Failure Syndrome. The company targets the substantial and underserved rotator cuff repair market, where failure rates range from 20% to 70%. Its technology leverages proprietary demineralized bone fiber processing (Bone Textile™) and shape-retention (FormLok™) to create a surgeon-friendly implant that promotes natural tissue regeneration. Led by an experienced entrepreneur and supported by clinical validation, Tetrous is positioned to commercialize a differentiated solution in sports medicine.
View full company profile